EDEN Stock Overview
Develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Eden Research plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.043 |
| 52 Week High | UK£0.08 |
| 52 Week Low | UK£0.036 |
| Beta | 0.93 |
| 11 Month Change | 2.35% |
| 3 Month Change | -10.31% |
| 1 Year Change | -42.00% |
| 33 Year Change | -52.97% |
| 5 Year Change | -57.97% |
| Change since IPO | -99.31% |
Recent News & Updates
Recent updates
We Think Eden Research (LON:EDEN) Can Afford To Drive Business Growth
Aug 25
We Think Eden Research (LON:EDEN) Needs To Drive Business Growth Carefully
Jul 09We're Keeping An Eye On Eden Research's (LON:EDEN) Cash Burn Rate
Mar 05We Think Eden Research (LON:EDEN) Needs To Drive Business Growth Carefully
Nov 06Companies Like Eden Research (LON:EDEN) Are In A Position To Invest In Growth
Jul 07We're Hopeful That Eden Research (LON:EDEN) Will Use Its Cash Wisely
Feb 18
A Look At Eden Research's (LON:EDEN) Share Price Returns
Dec 25We're Hopeful That Eden Research (LON:EDEN) Will Use Its Cash Wisely
Nov 19Shareholder Returns
| EDEN | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | -3.3% | 1.0% | -0.1% |
| 1Y | -42.0% | -30.6% | 5.4% |
Return vs Industry: EDEN underperformed the UK Chemicals industry which returned -31.4% over the past year.
Return vs Market: EDEN underperformed the UK Market which returned 5.7% over the past year.
Price Volatility
| EDEN volatility | |
|---|---|
| EDEN Average Weekly Movement | 6.5% |
| Chemicals Industry Average Movement | 6.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.7% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: EDEN has not had significant price volatility in the past 3 months.
Volatility Over Time: EDEN's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 19 | Sean Smith | www.edenresearch.com |
Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products.
Eden Research plc Fundamentals Summary
| EDEN fundamental statistics | |
|---|---|
| Market cap | UK£23.20m |
| Earnings (TTM) | -UK£6.49m |
| Revenue (TTM) | UK£3.19m |
7.3x
P/S Ratio-3.6x
P/E RatioIs EDEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EDEN income statement (TTM) | |
|---|---|
| Revenue | UK£3.19m |
| Cost of Revenue | UK£1.43m |
| Gross Profit | UK£1.77m |
| Other Expenses | UK£8.26m |
| Earnings | -UK£6.49m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 55.31% |
| Net Profit Margin | -203.45% |
| Debt/Equity Ratio | 0% |
How did EDEN perform over the long term?
See historical performance and comparison